Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease

Gastroenterology

Volumn 129, Issue 1, 2005, Pages 26-33

  Odashima, Masaru ^a   Bamias, Giorgos ^a   Rivera Nieves, Jesus ^a   Linden, Joel ^a   Nast, Cynthia C ^b   Moskaluk, Christopher A ^a   Marini, Marco ^a   Sugawara, Kazuhiko ^a   Kozaiwa, Kosuke ^a   Otaka, Michiro ^c   Watanabe, Sumio ^c   Cominelli, Fabio ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2A RECEPTOR AGONIST; ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; CYTOKINE; FORMALDEHYDE; PURINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLON; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; ILEITIS; IMMUNITY; LYMPH NODE; LYMPHOCYTE; MALE; MESENTERY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMAL; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; COLITIS; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; RABBIT; RECURRENT DISEASE;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COLITIS; CYCLOHEXANECARBOXYLIC ACIDS; CYTOKINES; DISEASE MODELS, ANIMAL; FORMALDEHYDE; ILEITIS; INFLAMMATORY BOWEL DISEASES; MALE; MICE; MICE, SCID; PURINES; RABBITS; RECEPTOR, ADENOSINE A2A; RECURRENCE;

EID: 22344435384     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.05.032     Document Type: Article

References (32)

1. G. Bouma, W. Strober The immunological and genetic basis of inflammatory bowel disease Nat Rev Immunol 3 2003 521 533
2. C. Fiocchi Inflammatory bowel disease etiology and pathogenesis Gastroenterology 115 1998 182 205
3. W.J. Sandborn, S.R. Targan Biologic therapy of inflammatory bowel disease Gastroenterology 122 2002 1592 1608
4. G. Bamias, K. Sugawara, C. Pagnini, F. Cominelli The Th1 immune pathway as a therapeutic target in Crohn's disease Curr Opin Investig Drugs 4 2003 1279 1286
5. J. Linden Molecular approach to adenosine receptors receptor-mediated mechanisms of tissue protection Annu Rev Pharmacol Toxicol 41 2001 775 787
6. G.W. Sullivan, J. Linden Role of adenosine receptors in inflammation Drug Dev Res 45 1998 103 112
7. B.N. Cronstein Adenosine, an endogenous anti-inflammatory agent J Appl Physiol 76 1994 5 13
8. 2A activation reduces lung reperfusion injury following transplantation J Heart Lung Transplant 18 1999 381 402
9. 2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion Am J Physiol Renal Physiol 279 2000 F809 F818
10. J.E. Jordan, Z.Q. Zhao, H. Sato, S. Taft, J. Vinten-Johansen Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation, and coronary endothelial adherence J Pharmacol Exp Ther 280 1997 301 309
11. N. Harada, K. Okajima, K. Murakami, S. Usune, C. Sato, K. Ohshima, T. Katsuragi Adenosine and selective A2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation J Pharmacol Exp Ther 294 2000 1034 1042
12. 2A receptor inhibits IL-12 production by human monocytes J Immunol 164 2000 436 442
13. 2A receptor-dependent and independent mechanisms FASEB J 14 2000 2065 2074
14. C.M. Lappas, J.M. Rieger, J. Linden A2A adenosine receptor induction inhibits IFN-γ production in murine CD4+ T cells J Immunol 174 2005 1073 1080
15. 2A adenosine receptor agonists J Med Chem 44 2001 531 539
16. F. Cominelli, C.C. Nast, B.D. Clark, R. Schindler, V.E. Eysselein, R.C. Thompson, C.A. Dinarello Interleukin-1 (IL-1) gene expression, synthesis, and effects of specific IL-1 receptor blockade in rabbit immune colitis J Clin Invest 86 1990 972 980
17. F. Cominelli, C.C. Nast, A. Duchini, M. Lee Recombinant interleukin 1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis Gastroenterology 103 1992 65 71
18. M.M. Kosiewicz, C.C. Nast, A. Krishnan, J. Rivera-Nieves, C.A. Moskaluk, S. Matsumoto, K. Kozaiwa, F. Cominelli Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease J Clin Invest 107 2001 695 702
19. J. Rivera-Nieves, G. Bamias, A. Vidrich, M. Marini, T.T. Pizarro, M.J. McDuffie, C.A. Moskaluk, S.M. Cohn, F. Cominelli Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis Gastroenterology 124 2003 972 982
20. M. Ferretti, V. Casini-Raggi, T.T. Pizarro, S.P. Eisenberg, C.C. Nast, F. Cominelli Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis J Clin Invest 94 1994 449 453
21. J.E. Krawisz, P. Sharon, W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
22. H2 cytokines in a murine model of chronic small intestinal inflammation Gastroenterology 128 2005 654 666
23. α s-linked) receptors J Exp Med 186 1997 1615 1620
24. I. Feoktistov, I. Biaggion Adenosine A2B receptors Pharmacol Rev 49 1997 381 402
25. G.W. Sullivan, J.M. Rieger, W.M. Scheld, T.L. MacDonald, J. Linden Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists Br J Pharmacol 32 2001 1017 1026
26. L. Morabito, M.C. Montesinos, D.M. Schreibman, L. Balter, L.F. Thompson, R. Resta, G. Carlin, M.A. Huie, B.N. Cronstein Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′- nucleotidase-mediated conversion of adenine nucleotides J Clin Invest 101 1998 295 300
27. M. Koshiba, H. Kojima, S. Huang, S. Apsov, M.V. Sitkovsky Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells J Biol Chem 272 1997 25881 25889
28. S. Huang, S. Apsov, M. Koshiba, M. Sitkovsky Role of A2A extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T cell activation and expansion Blood 90 1997 1600 1610
29. s protein-coupled A2A adenosine receptor in vivo J Immunol 173 2004 21 24
30. 2A receptor monoclonal antibodies Mol Pharmacol 55 1999 614 624
31. 2A adenosine receptor inhibits inflammation in rat model of meningitis synergy with the type IV phosphodiesterase inhibitor, rolipram J Infect Dis 180 1999 1550 1560
32. B. Siegmund, F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G.S. Firestein, D. Boyle, H.A. Lehr, F. Loher, G. Hartmann, S. Endres, A. Eigler Adenosine kinase inhibitor GP515 improves experimental colitis in mice J Pharmacol Exp Ther 296 2001 99 105